Prokidney Corp Stock Net Asset
| PROK Stock | USD 1.66 0.17 9.29% |
ProKidney Corp fundamentals help investors to digest information that contributes to ProKidney Corp's financial success or failures. It also enables traders to predict the movement of ProKidney Stock. The fundamental analysis module provides a way to measure ProKidney Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ProKidney Corp stock.
ProKidney | Net Asset |
ProKidney Corp Company Net Asset Analysis
ProKidney Corp's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current ProKidney Corp Net Asset | 420.55 M |
Most of ProKidney Corp's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ProKidney Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
ProKidney Net Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for ProKidney Corp is extremely important. It helps to project a fair market value of ProKidney Stock properly, considering its historical fundamentals such as Net Asset. Since ProKidney Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ProKidney Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ProKidney Corp's interrelated accounts and indicators.
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
ProKidney Total Assets
Total Assets |
|
Based on the recorded statements, ProKidney Corp has a Net Asset of 420.55 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
ProKidney Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ProKidney Corp's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ProKidney Corp could also be used in its relative valuation, which is a method of valuing ProKidney Corp by comparing valuation metrics of similar companies.ProKidney Corp is currently under evaluation in net asset category among its peers.
ProKidney Corp Institutional Holders
Institutional Holdings refers to the ownership stake in ProKidney Corp that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of ProKidney Corp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing ProKidney Corp's value.| Shares | Nuveen Asset Management, Llc | 2024-09-30 | 227.2 K | Bank Of New York Mellon Corp | 2024-09-30 | 190.5 K | Goldman Sachs Group Inc | 2024-09-30 | 188.1 K | Amundi | 2024-09-30 | 156 K | Barclays Plc | 2024-09-30 | 146.3 K | Alps Advisors Inc | 2024-09-30 | 97.4 K | Rhumbline Advisers | 2024-09-30 | 90.4 K | Alliancebernstein L.p. | 2024-09-30 | 84.2 K | Citigroup Inc | 2024-09-30 | 75.2 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 14.3 M | Suvretta Capital Management, Llc | 2024-09-30 | 12.3 M |
ProKidney Fundamentals
| Return On Equity | -0.31 | ||||
| Return On Asset | -0.2 | ||||
| Current Valuation | (187.95 M) | ||||
| Shares Outstanding | 127.97 M | ||||
| Shares Owned By Insiders | 27.43 % | ||||
| Shares Owned By Institutions | 43.37 % | ||||
| Number Of Shares Shorted | 10.26 M | ||||
| Price To Book | 91.32 X | ||||
| EBITDA | (147.67 M) | ||||
| Net Income | (135.45 M) | ||||
| Cash And Equivalents | 21.88 M | ||||
| Cash Per Share | 0.36 X | ||||
| Total Debt | 4.41 M | ||||
| Debt To Equity | 5.66 % | ||||
| Current Ratio | 0.74 X | ||||
| Book Value Per Share | (7.66) X | ||||
| Cash Flow From Operations | (90.07 M) | ||||
| Short Ratio | 23.97 X | ||||
| Earnings Per Share | (0.54) X | ||||
| Target Price | 4.67 | ||||
| Number Of Employees | 163 | ||||
| Beta | 1.31 | ||||
| Market Capitalization | 1.81 B | ||||
| Total Asset | 420.55 M | ||||
| Retained Earnings | (1.14 B) | ||||
| Working Capital | 349.11 M | ||||
| Net Asset | 420.55 M |
About ProKidney Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ProKidney Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ProKidney Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ProKidney Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out ProKidney Corp Piotroski F Score and ProKidney Corp Altman Z Score analysis. For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. If investors know ProKidney will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProKidney Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ProKidney Corp is measured differently than its book value, which is the value of ProKidney that is recorded on the company's balance sheet. Investors also form their own opinion of ProKidney Corp's value that differs from its market value or its book value, called intrinsic value, which is ProKidney Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProKidney Corp's market value can be influenced by many factors that don't directly affect ProKidney Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProKidney Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProKidney Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProKidney Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.